MRSA Infection Prevention and Patient Protection Act

S 2278/HR 4214, Community and Healthcare-Associated Infections Reduction Act S 2312/HR 3697, Strategies to Address Antimicrobial Resistance Act S 2525, MRSA Infection Prevention and Patient Protection Act HR 1174, Healthy Hospital Act

Client expense: $60,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

S 2278/HR 4214, Community and Healthcare-Associated Infections Reduction Act S 2312/HR 3697, Strategies to Address Antimicrobial Resistance Act S 2525, MRSA Infection Prevention and Patient Protection Act HR 1174, Healthy Hospital Act

Client expense: $60,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), SENATE

S 2278/HR 4214, Community and Healthcare-Associated Infections Reduction Act S 2312/HR 3697, Strategies to Address Antimicrobial Resistance Act S 2525, MRSA Infection Prevention and Patient Protection Act HR 1174, Healthy Hospital Act

Client expense: $60,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), SENATE

H.R.3251, Medicare Safe Needle Disposal Coverage Act of 2007, Issues related to sharps disposal S.1909, Medicare Safe Needle Disposal Coverage Act of 2007, Issues related to sharps disposal H.R. 5501, To authorize appropriations for fiscal years 2009 through 2013 to provide assistance to foreign countries to combat HIV/AIDS, tuberculosis, and malaria, and for other purposes, Issues related to HIV/AIDS and Tuberculosis S. 2731, A bill to authorize appropriations for fiscal years 2009 through 2013 to provide assistance to foreign countries to combat HIV/AIDS, tuberculosis, and malaria, and for other purposes, Issues related to funding for global assistance for HIV/AIDS, tuberculosis, malaria, and other diseases H.R.5839, Safeguarding America's Pharmaceuticals Act of 2008, Issues related to pedigree H.R.3697, Strategies to Address Antimicrobial Resistance Act, Issues relating to HAI/MRSA surveillance and prevention S. 2313, Strategies to Address Antimicrobial Resistance Act, Issues relating to HAI/MRSA surveillance and prevention S. 2278, Community and Healthcare-Associated Infections Reduction Act of 2007, Issues relating to HAI/MRSA surveillance and prevention H.R. 4214, Community and Healthcare-Associated Infections Reduction Act of 2007, Issues relating to HAI/MRSA surveillance and prevention S. 549, Preservation of Antibiotics for Medical Treatment Act of 2007, Issues relating to HAI/MRSA surveillance and prevention H.R. 962, Preservation of Antibiotics for Medical Treatment Act of 2007, Issues relating to HAI/MRSA surveillance and prevention S. 2525, MRSA Infection Prevention and Patient Protection Act, Issues relating to HAI/MRSA surveillance and prevention S. 2526, Worker Infection Protection Act, Issues relating to HAI/MRSA surveillance and prevention H.R. 4451, MRSA Research and Study Act of 2007, Issues relating to HAI/MRSA surveillance and prevention H.R. 1174, Healthy Hospitals Act of 2007, Issues relating to HAI/MRSA surveillance and prevention S. Res. 454, Designating the month of March 2008 as "MRSA Awareness Month", Issues relating to HAI/MRSA surveillance and prevention H. Res. 988, Designating the month of March 2008 as "MRSA Awareness Month", Issues relating to HAI/MRSA surveillance and prevention S. Res.454, A resolution designating the month of March 2008 as "MRSA Awareness Month" H.R. 6381, Medical Device Safety Act of 2008, Issues relating to pre-emption S. 3398, Medical Device Safety Act of 2008, Issues relating to pre-emption S.3409, Drug and Device Accountability Act of 2008, Issues relating to the FDA regulation of imported medical devices H.R.5839, Safeguarding America's Pharmaceuticals Act of 2008, Issues relating to drug pedigree

Medical Research Antibiotic Resistance issues H. R. 1174, Healthy Hospitals Act H. R. 3697, Strategies to Address Antimicrobial Resistance Act H. R. 4352, Antimicrobial Task Force in public schools H. R. 4451, MRSA Research and Study Act H.R. 1424, Emergency Economic Stabilization Act of 2008 H Res. 988, Designating the month of March 2008 as `MRSA Awareness Month' S. 2278, Community and Healthcare Associated Infections Reduction Act S. 2313, Strategies to Address Antimicrobial Resistance Act S. 2525, MRSA Infection Prevention and Patient Protection Act S. 2526, Worker Infection Protection Act S. 3560 QI Program Supplemental Funding Act of 2008 (Antibiotic Provision) S Res. 454, Designating the month of March 2008 as `MRSA Awareness Month'

Client expense: Not reported · Firm income: $40,000

Medical Research Prescription drug/Federal Drug Admin/Center for Disease Control/Health and Human Service issues Antibiotic Resistance issues H. R. 1174, Healthy Hospitals Act H. R. 3697, Strategies to Address Antimicrobial Resistance Act H. R. 4352, Antimicrobial Task Force in public schools H. R. 4451, MRSA Research and Study Act S. 2278, Community and Healthcare Associated Infections Reduction Act S. 2313, Strategies to Address Antimicrobial Resistance Act S. 2525, MRSA Infection Prevention and Patient Protection Act S. 2526, Worker Infection Protection Act S. 3560 QI Program Supplemental Funding Act of 2008 (Antibiotic Provision)

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

S. 2278/HR 4214, Community and Healthcare-Associated Infections Reduction Act S 2312/HR 3697 , Strategies to Address Antimicrobial Resistance Act S 2525, MRSA Infection Prevention and Patient Protection Act HR 1174, Helathy Hospitals Act

Client expense: $80,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S. 2278/HR 4214, Community and Healthcare-Associated Infections Reduction Act S 2312/HR 3697 , Strategies to Address Antimicrobial Resistance Act S 2525, MRSA Infection Prevention and Patient Protection Act HR 1174, Helathy Hospitals Act

Client expense: $80,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medical Research Prescription drug/Federal Drug Admin/Center for Disease Control/Health and Human Service issues Antibiotic Resistance issues H. R. 1174, Healthy Hospitals Act H. R. 3697, Strategies to Address Antimicrobial Resistance Act H. R. 4352, Antimicrobial Task Force in public schools H. R. 4451, MRSA Research and Study Act S. 2278, Community and Healthcare Associated Infections Reduction Act S. 2313, Strategies to Address Antimicrobial Resistance Act S. 2525, MRSA Infection Prevention and Patient Protection Act S. 2526, Worker Infection Protection Act

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

Medical Research Antibiotic Resistance issues H. R. 1174, Healthy Hospitals Act H. R. 3697, Strategies to Address Antimicrobial Resistance Act H. R. 4352, Antimicrobial Task Force in public schools H. R. 4451, MRSA Research and Study Act S. 2278, Community and Healthcare Associated Infections Reduction Act S. 2313, Strategies to Address Antimicrobial Resistance Act S. 2525, MRSA Infection Prevention and Patient Protection Act S. 2526, Worker Infection Protection Act S Res. 454, Designating the month of March 2008 as `MRSA Awareness Month'

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

Hospital associated infections (S 2278, S 2525, HR 1174) Mental health parity (HR 1424, S 558) Physician Payments Sunshine Act (HR 5605, S 2029) PRO(TECH)T Act (HR 6357) Transparency in Medical Device Pricing Act (S 2221) Wired for Health Quality Act (S 1693)

Client expense: $200,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medical Research Prescription Drug/Federal Drug Admin/Center for Disease Control/Health and Human Services Issues Antibiotic Resistance Issues H. R. 1174, Healthy Hospitals Act H. R. 3697, Strategies to Address Antimicrobial Resistance Act H. R. 4352, Antimicrobial Task Force in public schools H. R. 4451, MRSA Research and Study Act S. 2278, Community and Healthcare Associated Infections Reduction Act S. 2313, Strategies to Address Antimicrobial Resistance Act S. 2525, MRSA Infection Prevention and Patient Protection Act S. 2526, Worker Infection Protection Act

Client expense: $125,920 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

Medical Research Antibiotic Resistance Issues H. R. 1174, Healthy Hospitals Act H. R. 3697, Strategies to Address Antimicrobial Resistance Act H.R. 4352, Antimicrobial Task Force in public schools H. R. 4451, MRSA Research and Study Act S. 2278, Community and Healthcare Associated Infections Reduction Act S. 2313, Strategies to Address Antimicrobial Resistance Act S. 2525, MRSA Infection Prevention and Patient Protection Act S. 2526, Worker Infection Protection Act S. Res. 454, Designating the month of March 2008 as "MRSA Awareness Month"

Client expense: $125,920 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

S. 2029, Physician Payments Sunshine Act of 2007, Issues related to medical device company/physician relationship H.R. 5605, Physican Payments Sunshine Act of 2008, Issues related to medical device company/physician relationship H.R. 5501, To authorize appropriations for fiscal years 2009 through 2013 to provide assistance to foreign countries to combat HIV/AIDS, tuberculosis, and malaria, and for other purposes, Issues related to HIV/AIDS and Tuberculosis S. 2731, A bill to authorize appropriations for fiscal years 2009 through 2013 to provide assistance to foreign countries to combat HIV/AIDS, tuberculosis, and malaria, and for other purposes, Issues related to funding for global assistance for HIV/AIDS, tuberculosis, malaria, and other diseases H.R.5839, Safeguarding America's Pharmaceuticals Act of 2008, Issues related to pedigree H.R.3697, Strategies to Address Antimicrobial Resistance Act, Issues relating to HAI/MRSA surveillance and prevention S. 2313, Strategies to Address Antimicrobial Resistance Act, Issues relating to HAI/MRSA surveillance and prevention S. 2278, Community and Healthcare-Associated Infections Reduction Act of 2007, Issues relating to HAI/MRSA surveillance and prevention H.R. 4214, Community and Healthcare-Associated Infections Reduction Act of 2007, Issues relating to HAI/MRSA surveillance and prevention S. 549, Preservation of Antibiotics for Medical Treatment Act of 2007, Issues relating to HAI/MRSA surveillance and prevention H.R. 962, Preservation of Antibiotics for Medical Treatment Act of 2007, Issues relating to HAI/MRSA surveillance and prevention S. 2525, MRSA Infection Prevention and Patient Protection Act, Issues relating to HAI/MRSA surveillance and prevention S. 2526, Worker Infection Protection Act, Issues relating to HAI/MRSA surveillance and prevention H.R. 4451, MRSA Research and Study Act of 2007, Issues relating to HAI/MRSA surveillance and prevention H.R. 1174, Healthy Hospitals Act of 2007, Issues relating to HAI/MRSA surveillance and prevention S. Res. 454, Designating the month of March 2008 as "MRSA Awareness Month", Issues relating to HAI/MRSA surveillance and prevention H. Res. 988, Designating the month of March 2008 as "MRSA Awareness Month", Issues relating to HAI/MRSA surveillance and prevention Proposals to amend Social Security Act to support hospital efforts to prevent and treat healthcare acquired infections Proposed legislation relating to the FDA regulation of imported medical devices

S 2525--Veterans Compensation Equity Act of 2008--A bill to amend title 38, USC, to provide a minimum disability rating for veterans receiving medical treatment for a service-connected disability. S 2683--Amend title 38, USC, to modify certain authorities relating to educational assistance benefits for veterans and for other purposes--Amends federal provisions concerning veterans' educational assistance under the Montgomery GI Bill to: (1) allow the accelerated payment of such assistance for the pursuit of education leading to employment in high-technology industry only for programs of education which do not lead to an associate or higher degree; (2) terminate the June 30, 2010, delimiting period on an expanded scope of work activities that may be assigned to individuals participating in Department of Veterans Affairs (VA) work-study programs; and (3) authorize appropriations for VA payments to state agencies which approve programs of education for purposes of participation in the VA educational assistance program. S 2273--Enhanced Opportunities for Formerly Homeless Veterans Residing in Permanent Housing Act of 2007--A bill to enhance the functioning and integration of formerly homeless veterans who reside in permanent housing and for other purposes. S 2768--Provide a temporary increase in the maximum loan guaranty amount for certain housing loans guaranteed by the Secretary of Veterans Affairs--Provides a temporary increase, during the period beginning on the date of enactment of this Act and ending on December 31, 2011, in the maximum veterans' loan guaranty amount for housing loans guaranteed by the Department of Veterans Affairs. Testimony to House Committee on Veterans' Affairs--Ending Homelessness for Our Nations' Veterans--The American Legion supports various VA and DoD initiatives and urges greater support to end homelessness. Testimony to House Committee on Veterans' Affairs Subcommittee on Oversight and Investigation--VA and DoD Cooperation in Reintegration of National Guard and Reserves--The American Legion supports greater VA and Dod Cooperation and outreach to ensure a proper transition back to American home military and civilian life for all veterans. Testimony to House Veterans Affairs' Committee Subcommittee--Post Traumatic Stress Disorder Treatment and Research--The American Legion supports greater funding, treatment, and research against PTSD. Testimony to House Veterans Affairs' Committee Subcommittee on Disability Assistance and Memorial Affairs--Examining the Effectiveness of VBA Outreach Efforts--The American Legion support greater quality assurance, and greater intensity, of VBA outreach efforts. Public Law 101-510--Enhanced services could improve transition Assistance for Reserve and National Guard--To assist service members who possessed certain critical military specialties that could not be easily transferred to civilian work environment and to assist others with educational and career choices.

H.R.3697, Strategies to Address Antimicrobial Resistance Act, Issues relating to HAI/MRSA surveillance and prevention S. 2313, Strategies to Address Antimicrobial Resistance Act, Issues relating to HAI/MRSA surveillance and prevention S. 2278, Community and Healthcare-Associated Infections Reduction Act of 2007, Issues relating to HAI/MRSA surveillance and prevention H.R. 4214, Community and Healthcare-Associated Infections Reduction Act of 2007, Issues relating to HAI/MRSA surveillance and prevention S. 549, Preservation of Antibiotics for Medical Treatment Act of 2007, Issues relating to HAI/MRSA surveillance and prevention H.R. 962, Preservation of Antibiotics for Medical Treatment Act of 2007, Issues relating to HAI/MRSA surveillance and prevention S. 2525, MRSA Infection Prevention and Patient Protection Act, Issues relating to HAI/MRSA surveillance and prevention S. 2526, Worker Infection Protection Act, Issues relating to HAI/MRSA surveillance and prevention H.R. 4451, MRSA Research and Study Act of 2007, Issues relating to HAI/MRSA surveillance and prevention H.R. 1174, Healthy Hospitals Act of 2007, Issues relating to HAI/MRSA surveillance and prevention H.R. 4352, To provide $30,000,000 in funding to the Department of Education to provide assistance to public school districts for the prevention of drug resistant infections, Issues relating to HAI/MRSA surveillance and prevention S. Res. 454, Designating the month of March 2008 as "MRSA Awareness Month", Issues relating to HAI/MRSA surveillance and prevention H. Res. 988, Designating the month of March 2008 as "MRSA Awareness Month", Issues relating to HAI/MRSA surveillance and prevention

Client expense: $250,000 · Firm income: Not reported

Medical Research Prescription drug/Federal Drug Admin/Center for Disease Control/Health and Human Service issues Antibiotic Resistance issues H. R. 1174, Healthy Hospitals Act H. R. 3697, Strategies to Address Antimicrobial Resistance Act H. R. 4352, Antimicrobial Task Force in public schools H. R. 4451, MRSA Research and Study Act S. 2278, Community and Healthcare Associated Infections Reduction Act S. 2313, Strategies to Address Antimicrobial Resistance Act S. 2525, MRSA Infection Prevention and Patient Protection Act S. 2526, Worker Infection Protection Act

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

Medical Research Antibiotic Resistance issues H. R. 1174, Healthy Hospitals Act H. R. 3697, Strategies to Address Antimicrobial Resistance Act H. R. 4352, Antimicrobial Task Force in public schools H. R. 4451, MRSA Research and Study Act S. 2278, Community and Healthcare Associated Infections Reduction Act S. 2313, Strategies to Address Antimicrobial Resistance Act S. 2525, MRSA Infection Prevention and Patient Protection Act S. 2526, Worker Infection Protection Act

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

Medical Research Prescription drug/Federal Drug Admin/Center for Disease Control/Health and Human Service issues Antibiotic Resistance issues H.R. 1174, Healthy Hospitals Act H.R. 3697, Strategies to Address Antimicrobial Resistance Act H.R. 4352, Antimicrobial Task Force in public schools H.R. 4451, MRSA Research and Study Act S. 2278, Community and Healthcare Associated Infections Reduction Act S. 2313, Strategies to Address Antimicrobial Resistance Act S. 2525, MRSA Infection Prevention and Patient Protection Act S. 2526, Worker Infection Protection Act

Client expense: $131,330 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

Medical Research Antibiotic Resistance issues H.R. 1174, Healthy Hospitals Act H.R. 3697, Strategies to Address Antimicrobial Resistance Act H.R. 4352, Antimicrobial Task Force in public schools H.R. 4451, MRSA Research & Study Act S. 2278, Community and Healthcare Associated Infections Reduction Act S. 2313, Strategies to Address Antimicrobial Resistance Act S. 2525, MRSA Infection Prevention and Patient Protection Act S 2526, Worker Infection Protection Act

Client expense: $131,330 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

HR 3162, HR 976 - Children's Health & Medicare Protection Act of 2007 HR 3963, S 1893 - State Children's Health Insurance Program reauthorization and extension S 2499 - Medicare, Medicaid and SCHIP Extension Act of 2007 HR 3043 - Camp Amendment to Labor, HHS, Education Appropriations FY 2008 HR 2034, S 1218, HR 1841, HR 676 - Health Care Reform HR 3995 - Protecting the interests of residents of intermediate care facilities for the mentally retarded HR 2122, S 1842 - Safe Nursing and Patient Care Act of 2007 HR 1638, HR 3543 - James Zadroga 9/11 Health and Compensation Act (Long-term monitoring, treatment and compensation for workers made ill by work at Ground Zero in NYC) Ensuring adequate planning to protect health care and emergency workers from exposure during public health emergencies S 2525 - MRSA Infection Prevention and Patient Protection Act S 2526 - Worker Infection Protection Act S 1693 - Wired for Health Care Quality Act S 1695 - Generic biotech drugs HR 3932, S 2219 - Medicare Prescription Drug Savings and Choice Act of 2007 HR 1424 - Paul Wellstone Mental Health and Addiction Equity Act of 2007

Client expense: $1,240,000 · Firm income: Not reported